Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder
Clinical trial NCT01939353 · COMPLETED
Trial details
- NCT number
- NCT01939353
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-03
- Primary completion
- 2014-02-20
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.